109 related articles for article (PubMed ID: 16080387)
1. Plasma concentrations of vascular endothelial growth factor and basic fibroblast growth factor in lymphoproliferative disorders.
Smolej L; Andrýs C; Maisnar V; Pour L; Malý J
Acta Medica (Hradec Kralove); 2005; 48(1):57-8. PubMed ID: 16080387
[TBL] [Abstract][Full Text] [Related]
2. [Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment].
Smolej L; Andrýs C; Krejsek J; Belada DZ; Zák P; Siroký O; Malý J
Vnitr Lek; 2007 Nov; 53(11):1171-6. PubMed ID: 18277626
[TBL] [Abstract][Full Text] [Related]
3. Angiogenic and coagulation-fibrinolysis factors in non Hodgkin's lymphoma.
Wróbel T; Poreba M; Mazur G; Poreba R; Pyszel A; Beck B; Steinmetz-Beck A; Andrzejak R; Kuliczkowski K
Neoplasma; 2006; 53(3):253-8. PubMed ID: 16652197
[TBL] [Abstract][Full Text] [Related]
4. [Circulating endothelial cells, endothelial precursors, VEGF and bFGF concentrations in patients with acute leukemias, lymphomas and myelomas].
Poreba M; Jaźwiec B; Kuliczkowski K; Poreba R
Pol Arch Med Wewn; 2005 Jan; 113(1):27-34. PubMed ID: 16130598
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2 expression correlates positively with serum basic fibroblast growth factor (bFGF) and negatively with cellular vascular endothelial growth factor (VEGF) in patients with chronic lymphocytic leukaemia.
Bairey O; Zimra Y; Shaklai M; Rabizadeh E
Br J Haematol; 2001 May; 113(2):400-6. PubMed ID: 11380405
[TBL] [Abstract][Full Text] [Related]
6. Circulating angiogenic cytokines in multiple myeloma and related disorders.
Urba ska-Rys H; Wierzbowska A; Robak T
Eur Cytokine Netw; 2003; 14(1):40-51. PubMed ID: 12799213
[TBL] [Abstract][Full Text] [Related]
7. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood.
Di Raimondo F; Azzaro MP; Palumbo G; Bagnato S; Giustolisi G; Floridia P; Sortino G; Giustolisi R
Haematologica; 2000 Aug; 85(8):800-5. PubMed ID: 10942925
[TBL] [Abstract][Full Text] [Related]
8. Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?
Tabone MD; Landman-Parker J; Arcil B; Coudert MC; Gerota I; Benbunan M; Leverger G; Dosquet C
Clin Cancer Res; 2001 Mar; 7(3):538-43. PubMed ID: 11297245
[TBL] [Abstract][Full Text] [Related]
9. [Expression of bFGF and VEGF in acute leukemia and its effects on HL-60 cell growth].
Zhang WP; Chun XQ; Zhang YQ; Liang R; Li YH; Gao GX; Zhu HF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):91-4. PubMed ID: 15748443
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of vascular endothelial growth factor and basic fibroblast growth factor in children with brain tumors.
Sobol-Milejska G; Mizia-Malarz A; Musiol K; Chudek J; Bożentowicz-Wikarek M; Wos H; Mandera M
Adv Clin Exp Med; 2017 Jul; 26(4):571-575. PubMed ID: 28691414
[TBL] [Abstract][Full Text] [Related]
11. Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia.
Gora-Tybor J; Blonski JZ; Robak T
Mediators Inflamm; 2003 Jun; 12(3):167-71. PubMed ID: 12857600
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of basic fibroblast growth factor and vascular endothelial growth factor and their association with IgVH mutation status in patients with B-cell chronic lymphocytic leukemia.
Smolej L; Andrys C; Peková S; Schwarz J; Belada D; Zák P
Haematologica; 2006 Oct; 91(10):1432-3. PubMed ID: 17018398
[TBL] [Abstract][Full Text] [Related]
13. Modern prognostic factors and angiogenesis in chronic lymphocytic leukemia: more data needed.
Smolej L; Andrys C; Vroblova V
Leuk Res; 2007 Dec; 31(12):1763-4. PubMed ID: 17617454
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of proangiogenic cytokines in children with lymphomas.
Mizia-Malarz A; Sobol G; Janowska J; Wos H; Zahorska-Markiewicz B
Pediatr Blood Cancer; 2009 Dec; 53(7):1195-9. PubMed ID: 19621434
[TBL] [Abstract][Full Text] [Related]
15. Circulating sCD138 and some angiogenesis-involved cytokines help to anticipate the disease progression of early-stage B-cell chronic lymphocytic leukemia.
Wołowiec D; Dybko J; Wróbel T; Urbaniak-Kujda D; Jaźwiec B; Tomaszewska-Toporska B; Kapelko-Słowik K; Potoczek S; Kuliczkowski K
Mediators Inflamm; 2006; 2006(3):42394. PubMed ID: 16951490
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor and basic fibroblast growth factor are found in resolving venous thrombi.
Waltham M; Burnand KG; Collins M; Smith A
J Vasc Surg; 2000 Nov; 32(5):988-96. PubMed ID: 11054231
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of VEGF and bFGF in hypoxic patients with exacerbated COPD.
Pavlisa G; Pavlisa G; Kusec V; Kolonic SO; Markovic AS; Jaksic B
Eur Cytokine Netw; 2010 Jun; 21(2):92-8. PubMed ID: 20504760
[TBL] [Abstract][Full Text] [Related]
18. Angiogenesis factor pattern differs in acute lymphoblastic leukemia and chronic lymphocytic leukemia.
Aref S; Salama O; Shamaa S; El-Refaie M; Mourkos H
Hematology; 2007 Aug; 12(4):319-24. PubMed ID: 17654059
[TBL] [Abstract][Full Text] [Related]
19. Elevated level of plasma basic fibroblast growth factor in multiple myeloma correlates with increased disease activity.
Sato N; Hattori Y; Wenlin D; Yamada T; Kamata T; Kakimoto T; Okamoto S; Kawamura C; Kizaki M; Shimada N; Ote Y; Hata J; Ikeda Y
Jpn J Cancer Res; 2002 Apr; 93(4):459-66. PubMed ID: 11985797
[TBL] [Abstract][Full Text] [Related]
20. Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes.
Aguayo A; Kantarjian HM; Estey EH; Giles FJ; Verstovsek S; Manshouri T; Gidel C; O'Brien S; Keating MJ; Albitar M
Cancer; 2002 Nov; 95(9):1923-30. PubMed ID: 12404286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
